Showing results (21-30 of 112) with videos related to

Sort By:
Pageof 12
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2011
Activation of Wnt signaling arrests effector differentiation in human peripheral and cord blood-derived T lymphocytesSujatha Muralidharan, Patrick J Hanley, Enli Liu, et al.
Cancer|June 15, 2007
Novel tyrosine kinase inhibitor therapy before allogeneic stem cell transplantation in patients with chronic myeloid leukemia: no evidence for increased transplant-related toxicityElias Jabbour, Jorge Cortes, Hagop Kantarjian, et al.
Cancer|August 25, 2005
Quality of life among patients with Stage II and III breast carcinoma randomized to receive high-dose chemotherapy with autologous bone marrow support or intermediate-dose chemotherapy: results from Cancer and Leukemia Group B 9066Jeffrey Peppercorn, James Herndon, Alice B Kornblith, et al.
Acta Haematologica|May 22, 2019
Proteomic Profiling of Signaling Networks Modulated by G-CSF/Plerixafor/Busulfan-Fludarabine Conditioning in Acute Myeloid Leukemia Patients in Remission or with Active Disease prior to Allogeneic Stem Cell TransplantationZhihong Zeng, Wenbin Liu, Christopher B Benton, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 11, 2019
A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host DiseasePartow Kebriaei, Jack Hayes, Andrew Daly, et al.
Cytotherapy|December 31, 2016
Comparison of two methodologies for the enrichment of mononuclear cells from thawed cord blood products: The automated Sepax system versus the manual Ficoll methodIndreshpal Kaur, Jane M Zulovich, Marissa Gonzalez, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 27, 2007
Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatmentBetul Oran, Michele Donato, Ana Aleman, et al.
Research Square|March 11, 2024
Hu8F4-CAR T cells with mutated Fc spacer segment improve target-specificity and mediate anti-leukemia activity in vivoJeffrey Molldrem, Hong He, Rolando Vedia, et al.
Stem Cells Translational Medicine|May 13, 2018
Allogeneic Umbilical Cord Blood Infusion for Adults with Ischemic Stroke: Clinical Outcomes from a Phase I Safety StudyDaniel T Laskowitz, Ellen R Bennett, Rebecca J Durham, et al.
Seminars in Oncology Nursing|October 11, 2021
The Unique Symptom Burden of Patients Receiving CAR T-Cell TherapyMeagan S Whisenant, Samer A Srour, Loretta A Williams, et al.
Pageof 12